BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
241 hedge funds and large institutions have $5.87B invested in bluebird bio in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 81 increasing their positions, 78 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less call options, than puts
Call options by funds: $81.7M | Put options by funds: $103M
26% less capital invested
Capital invested by funds: $7.92B → $5.87B (-$2.05B)
56% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 54
Holders
241
Holding in Top 10
2
Calls
$81.7M
Puts
$103M
Top Buyers
| 1 | +$98.4M | |
| 2 | +$87.6M | |
| 3 | +$72.6M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$32.3M |
| 5 |
CII
Capital International Inc
Los Angeles,
California
|
+$30.6M |
Top Sellers
| 1 | -$70.5M | |
| 2 | -$41.9M | |
| 3 | -$37.1M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$22.2M |
| 5 |
Goldman Sachs
New York
|
-$20.1M |